Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer's Disease.

Molecules · 2025 · PMC12301006 · PMID 40733241

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

IC 50 = 0.37 and 0.27 μM, respectively, suggesting that N -benzylpiperidine substitution might be significant to the development of chromone-based dual inhibitors.

also in 2,457 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.